Asifa Habib
Examiner (ID: 14131, Phone: (571)270-7032 , Office: P/2887 )
Most Active Art Unit | 2887 |
Art Unit(s) | 2887, 2876 |
Total Applications | 354 |
Issued Applications | 240 |
Pending Applications | 39 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5687746
[patent_doc_number] => 20060286061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Amide esters as hydrocarbon gellants'
[patent_app_type] => utility
[patent_app_number] => 11/450847
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4829
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286061.pdf
[firstpage_image] =>[orig_patent_app_number] => 11450847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/450847 | Amide esters as hydrocarbon gellants | Jun 11, 2006 | Abandoned |
Array
(
[id] => 5794038
[patent_doc_number] => 20060014719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Method for treating neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/181094
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5779
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181094 | Method for treating neurodegenerative diseases | Jul 12, 2005 | Abandoned |
Array
(
[id] => 7250371
[patent_doc_number] => 20050272695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Fast dissolving dried hyaluronic acid product'
[patent_app_type] => utility
[patent_app_number] => 11/132828
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12182
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132828 | Fast dissolving dried hyaluronic acid product | May 18, 2005 | Abandoned |
Array
(
[id] => 7172381
[patent_doc_number] => 20050203073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Method of treating inflammatory conditions with progesterone or progesterone analogs'
[patent_app_type] => utility
[patent_app_number] => 11/074938
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5963
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074938
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074938 | Method of treating inflammatory conditions with progesterone or progesterone analogs | Mar 8, 2005 | Abandoned |
Array
(
[id] => 7075386
[patent_doc_number] => 20050148654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Statin-carboxyalkylether combinations'
[patent_app_type] => utility
[patent_app_number] => 11/067847
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7775
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067847 | Statin-carboxyalkylether combinations | Feb 27, 2005 | Abandoned |
Array
(
[id] => 5766958
[patent_doc_number] => 20060018952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Molecular reactive chitosan finishing agent used for textile'
[patent_app_type] => utility
[patent_app_number] => 11/013895
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 456
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013895
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013895 | Molecular reactive chitosan finishing agent used for textile | Dec 14, 2004 | Abandoned |
Array
(
[id] => 6905132
[patent_doc_number] => 20050100527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Compounds for delivering substances into cells'
[patent_app_type] => utility
[patent_app_number] => 11/007267
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 6132
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100527.pdf
[firstpage_image] =>[orig_patent_app_number] => 11007267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/007267 | Compounds for delivering substances into cells | Dec 8, 2004 | Abandoned |
Array
(
[id] => 6906295
[patent_doc_number] => 20050101690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Dye for an intraocular lens and an intraocular lens using it'
[patent_app_type] => utility
[patent_app_number] => 10/966752
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4981
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966752 | Dye for an intraocular lens and an intraocular lens using it | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7238333
[patent_doc_number] => 20050080099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods and kits for treating depression or preventing deterioration of cognitive function'
[patent_app_type] => utility
[patent_app_number] => 10/956896
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12437
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956896 | Methods and kits for treating depression or preventing deterioration of cognitive function | Sep 29, 2004 | Abandoned |
Array
(
[id] => 6972416
[patent_doc_number] => 20050038126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/933297
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6898
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038126.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933297 | Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7128001
[patent_doc_number] => 20050059745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Antiviral therapy'
[patent_app_type] => utility
[patent_app_number] => 10/929113
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10495
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059745.pdf
[firstpage_image] =>[orig_patent_app_number] => 10929113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/929113 | Antiviral therapy | Aug 25, 2004 | Abandoned |
Array
(
[id] => 7216954
[patent_doc_number] => 20050054688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Selective serotonin reuptake inhibitors in the treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 10/911806
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3882
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10911806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/911806 | Selective serotonin reuptake inhibitors in the treatment of disease | Aug 4, 2004 | Abandoned |
Array
(
[id] => 868823
[patent_doc_number] => 07365097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-29
[patent_title] => 'Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent'
[patent_app_type] => utility
[patent_app_number] => 10/899398
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4470
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/365/07365097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899398 | Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent | Jul 26, 2004 | Issued |
Array
(
[id] => 7264960
[patent_doc_number] => 20040242496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Phosphate suspensions'
[patent_app_type] => new
[patent_app_number] => 10/483926
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1561
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483926 | Phosphate suspensions | Jun 30, 2004 | Abandoned |
Array
(
[id] => 7040702
[patent_doc_number] => 20050159471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/845574
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23943
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159471.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845574 | Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system | May 12, 2004 | Abandoned |
Array
(
[id] => 7156202
[patent_doc_number] => 20050026919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/844921
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30545
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844921 | Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system | May 12, 2004 | Abandoned |
Array
(
[id] => 7297727
[patent_doc_number] => 20040214891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition'
[patent_app_type] => new
[patent_app_number] => 10/825288
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5282
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825288 | Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7410176
[patent_doc_number] => 20040176344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'METHOD TO TREAT PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS AND THE LIKE'
[patent_app_type] => new
[patent_app_number] => 10/708991
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3743
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176344.pdf
[firstpage_image] =>[orig_patent_app_number] => 10708991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/708991 | METHOD TO TREAT PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS AND THE LIKE | Apr 5, 2004 | Abandoned |
Array
(
[id] => 7346832
[patent_doc_number] => 20040192649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Skin care compositions containing a sugar amine'
[patent_app_type] => new
[patent_app_number] => 10/814759
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19579
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814759 | Skin care compositions containing a sugar amine | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7378055
[patent_doc_number] => 20040220155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith'
[patent_app_type] => new
[patent_app_number] => 10/803145
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44484
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803145 | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith | Mar 16, 2004 | Abandoned |